Search
SOLACI Congress
HomeCoronary diseaseChronic Coronary Syndromes

Chronic Coronary Syndromes

View Category

Acute coronary syndromes

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized...
Dr. Carlos Fava -
Learn More
Chronic Coronary Syndromes

Plaque Morphology and Stent Elongation Assessed by OCT

Second and third generation drug eluting stents (DES) have thin or ultrathin struts and a scaffold that...
Dr. Omar Tupayachi -
Learn More
Chronic Coronary Syndromes

Intramural Hematoma and “Cuttering” as a Rescue Technique

Coronary dissections can be self-limiting or they can progress, generating an intramural hematoma (IMH). The false lumen...
Dr. Omar Tupayachi -
Learn More
Chronic Coronary Syndromes

Long Term Outcomes of RIBS VI, a Study on Bioresorbable Stents in Patients with In-Stent Restenosis

The use of drug eluting stents (DES) is currently recommended for the percutaneous treatment of coronary artery...
Dr. Andrés Rodríguez -
Learn More
Chronic Coronary Syndromes

Microvascular Dysfunction from Coronary AngioCT? Vascular Remodeling Tiff-Off

Angina Patients studied invasively will show a significant proportion of non-obstructive coronary artery disease (ANOCA). From this...
Dr. Omar Tupayachi -
Learn More
Chronic Coronary Syndromes

ESC 2024 | REC-CAGEREE I Trial: Drug Coated Balloon with Bailout Stenting vs. Intended DES for de Novo Lesion Treatment

DES stenting is currently the standard treatment. The development of balloon technology and the coating drugs have...
Dr. Omar Tupayachi -
Learn More
Acute coronary syndromes

ESC 2024 | The OCCUPI Trial: Guided PCI for OCT in Complex Lesions

The aim of this stud was to compare the clinical benefits of OCT guided PCI (optical coherence...
Dr. Omar Tupayachi -
Learn More
Acute coronary syndromes

ESC 2024 | SCOFF Trial: Fasting or No Fasting before Cardiac Catheterization Procedures

Millions of people undergo either diagnostic or therapeutic coronary procedures that require sedation. The aim of this...
Dr. Omar Tupayachi -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy